NCT02726763 Feasibility and Tolerability of Transcranial Direct Current Stimulation With Concurrent Cognitive Training Status ACTIVE_NOT_RECRUITING Phase NA
NCT02726399 Phase II Study of Ramucirumab With Chemotherapy in Patients With Metastatic Gastroesophageal Junction and Gastric Cancer Status TERMINATED Phase PHASE2
NCT02725684 Using Genomic Analysis to Guide Individual Treatment in Glioblastoma Status COMPLETED Phase N/A
NCT02717949 Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study Status TERMINATED Phase PHASE4
NCT02713334 Cancer Patients Decision Making and Family Communication About Secondary Findings From Tumor Genomic Profiling Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02710058 Experience of Arab American Women With Breast Cancer: In-depth Interviews Status COMPLETED Phase N/A
NCT02706561 Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery Status RECRUITING Phase NA
NCT02702453 True NTH Sexual Recovery Intervention for Prostate Cancer Survivors and Their Partners Status COMPLETED Phase NA
NCT02701829 Taxi METERS: Measuring Effectiveness of Technology, Education, Referrals and Support Status COMPLETED Phase NA
NCT02697396 Trial of a Social Marketing Campaign to Increase HPV Vaccination Among Mexican American Children Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02697383 Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot Study Status COMPLETED Phase PHASE1
NCT02697357 Emotion Regulation Therapy to Address Distress Among Caregivers Status COMPLETED Phase N/A
NCT02684253 Screening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Status COMPLETED Phase PHASE2
NCT02682316 Negative Pressure Wound Therapy in Post-Operative Incision Management Status COMPLETED Phase PHASE3
NCT02677064 Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia Status RECRUITING Phase N/A
NCT02675829 Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02673333 Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2